The history and future of targeting cyclin-dependent kinases in cancer therapy

U Asghar, AK Witkiewicz, NC Turner… - Nature reviews Drug …, 2015 - nature.com
Cancer represents a pathological manifestation of uncontrolled cell division; therefore, it has
long been anticipated that our understanding of the basic principles of cell cycle control …

Inhibitors of cyclin-dependent kinases as cancer therapeutics

SR Whittaker, A Mallinger, P Workman… - Pharmacology & …, 2017 - Elsevier
Over the past two decades there has been a great deal of interest in the development of
inhibitors of the cyclin-dependent kinases (CDKs). This attention initially stemmed from …

[HTML][HTML] A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phase

DG Kirova, K Judasova, J Vorhauser, T Zerjatke… - Developmental cell, 2022 - cell.com
Reactive oxygen species (ROS) at the right concentration promote cell proliferation in cell
culture, stem cells, and model organisms. However, the mystery of how ROS signaling is …

NeoPalAna: neoadjuvant palbociclib, a cyclin-dependent kinase 4/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor–positive breast cancer

CX Ma, F Gao, J Luo, DW Northfelt, M Goetz… - Clinical Cancer …, 2017 - AACR
Purpose: Cyclin-dependent kinase (CDK) 4/6 drives cell proliferation in estrogen receptor–
positive (ER+) breast cancer. This single-arm phase II neoadjuvant trial (NeoPalAna) …

Cell cycle, CDKs and cancer: a changing paradigm

M Malumbres, M Barbacid - Nature reviews cancer, 2009 - nature.com
Tumour-associated cell cycle defects are often mediated by alterations in cyclin-dependent
kinase (CDK) activity. Misregulated CDKs induce unscheduled proliferation as well as …

SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond

T Schaefer, C Lengerke - Oncogene, 2020 - nature.com
Research of the past view years expanded our understanding of the various physiological
functions the cell-fate determining transcription factor SOX2 exerts in ontogenesis …

CDK inhibitors: positive and negative regulators of G1-phase progression

CJ Sherr, JM Roberts - Genes & development, 1999 - genesdev.cshlp.org
Mitogen-dependent progression through the first gap phase (G1) and initiation of DNA
synthesis (S phase) during the mammalian cell division cycle are cooperatively regulated by …

ATR inhibition induces CDK1–SPOP signaling and enhances anti–PD-L1 cytotoxicity in prostate cancer

Z Tang, PG Pilié, C Geng, GC Manyam, G Yang… - Clinical Cancer …, 2021 - AACR
Purpose: Despite significant benefit for other cancer subtypes, immune checkpoint blockade
(ICB) therapy has not yet been shown to significantly improve outcomes for men with …

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

J Lupberger, MB Zeisel, F Xiao, C Thumann, I Fofana… - Nature medicine, 2011 - nature.com
Hepatitis C virus (HCV) is a major cause of liver disease, but therapeutic options are limited
and there are no prevention strategies. Viral entry is the first step of infection and requires …

Cyclin-dependent kinases: engines, clocks, and microprocessors

DO Morgan - Annual review of cell and developmental biology, 1997 - annualreviews.org
▪ Abstract Cyclin-dependent kinases (Cdks) play a well-established role in the regulation of
the eukaryotic cell division cycle and have also been implicated in the control of gene …